Erwin Irdam Biogen

Erwin Irdam is a senior principal engineer at Biogen. Prior to joining Biogen in 2009 he was a research investigator at GlaxoSmithKline and before that as an associate Research Fellow at Pfizer. Throughout his career in API process research and development since 1992 to present, he has been involved in all phases of development from early to late stage, product launches, and life cycle management. He was active in the International Symposium for Innovation and Quality (IQ) where he contributed to the Quality by Design working group in publishing Industrial case studies for Drug Substance Control Strategies. He is currently served in Enabling Technology Consortium (ETC) as a member of the Board of Directors as well as a member of Crystallization and Modeling Cloud working groups. He holds a Doctoral degree in Chemical Engineering from the University of Illinois at Chicago. He is currently working in high-profile Biogen projects utilizing process synthesis optimization, crystallization and particle engineering, chemical kinetics, modeling and development of pharmaceutical continuous processing technologies.